U.S. Physical Therapy Stock Forecast, Price & News

+5.02 (+4.78 %)
(As of 04/16/2021 12:00 AM ET)
Today's Range
Now: $109.94
50-Day Range
MA: $112.44
52-Week Range
Now: $109.94
Volume81,500 shs
Average Volume77,367 shs
Market Capitalization$1.42 billion
P/E Ratio46.78
Dividend Yield1.27%
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of October 9, 2020, it operated 549 outpatient physical therapy clinics in 39 states; and managed 38 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.
U.S. Physical Therapy logo

Industry, Sector and Symbol

Industry Health services
Sub-IndustryHealth Care Facilities
Year FoundedN/A



Sales & Book Value

Annual Sales$481.97 million
Cash Flow$3.06 per share
Book Value$18.92 per share


Net Income$40.04 million


Market Cap$1.42 billion
Next Earnings Date5/6/2021 (Confirmed)


U.S. Physical Therapy EPS beats by $0.02, beats on revenue
February 26, 2021 |  seekingalpha.com
See More Headlines


Overall MarketRank

1.31 out of 5 stars

Medical Sector

795th out of 2,024 stocks

Health Services Industry

3rd out of 10 stocks

Analyst Opinion: 1.0Community Rank: 2.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
+5.02 (+4.78 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

Is U.S. Physical Therapy a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" U.S. Physical Therapy stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in USPH, but not buy additional shares or sell existing shares.
View analyst ratings for U.S. Physical Therapy
or view top-rated stocks.

What stocks does MarketBeat like better than U.S. Physical Therapy?

Wall Street analysts have given U.S. Physical Therapy a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but U.S. Physical Therapy wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for U.S. Physical Therapy

How can I listen to U.S. Physical Therapy's earnings call?

U.S. Physical Therapy will be holding an earnings conference call on Thursday, May 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) posted its quarterly earnings data on Thursday, February, 25th. The company reported $0.85 EPS for the quarter, topping the Zacks' consensus estimate of $0.83 by $0.02. The company earned $117.47 million during the quarter, compared to analyst estimates of $118.08 million. U.S. Physical Therapy had a net margin of 7.21% and a trailing twelve-month return on equity of 11.20%.
View U.S. Physical Therapy's earnings history

How has U.S. Physical Therapy's stock been impacted by Coronavirus (COVID-19)?

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, USPH shares have increased by 17.9% and is now trading at $109.94.
View which stocks have been most impacted by COVID-19

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Friday, February 26th. Stockholders of record on Friday, March 12th will be given a dividend of $0.35 per share on Friday, April 9th. This represents a $1.40 dividend on an annualized basis and a yield of 1.27%. The ex-dividend date of this dividend is Thursday, March 11th. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.32.
View U.S. Physical Therapy's dividend history

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy pays an annual dividend of $1.40 per share and currently has a dividend yield of 1.27%. U.S. Physical Therapy does not yet have a strock track record of dividend growth. The dividend payout ratio of U.S. Physical Therapy is 49.65%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 46.98% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.
View U.S. Physical Therapy's dividend history.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy updated its FY21 earnings guidance on Thursday, February, 25th. The company provided earnings per share (EPS) guidance of $2.40-2.52 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.00.

What price target have analysts set for USPH?

2 analysts have issued 1 year price objectives for U.S. Physical Therapy's stock. Their forecasts range from $100.00 to $100.00. On average, they anticipate U.S. Physical Therapy's stock price to reach $100.00 in the next twelve months. This suggests that the stock has a possible downside of 9.0%.
View analysts' price targets for U.S. Physical Therapy
or view top-rated stocks among Wall Street analysts.

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the following people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 57, Pay $1.3M)
  • Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 64, Pay $804.07k)
  • Mr. Graham D. Reeve M.B.A., P.T., Chief Operating Officer of East (Age 57, Pay $793.34k)
  • Mr. Carey P. Hendrickson, Chief Financial Officer (Age 59)
  • Mr. Richard S. Binstein, Gen. Counsel & Sec.
  • Mr. Jon C. Bates, VP & Corp. Controller
  • Johnny J. Blanchard, Assistant Controller

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy CEO Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among U.S. Physical Therapy's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of U.S. Physical Therapy's key competitors?

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of institutional and retail investors. Top institutional investors include Scout Investments Inc. (0.80%), Fenimore Asset Management Inc. (0.59%), State of Alaska Department of Revenue (0.07%), Louisiana State Employees Retirement System (0.04%) and Everence Capital Management Inc. (0.02%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson.
View institutional ownership trends for U.S. Physical Therapy

Which major investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, and Louisiana State Employees Retirement System. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Edward L Kuntz, Graham D Reeve, Harry S Chapman, Lawrance W Mcafee, and Mark J Brookner.
View insider buying and selling activity for U.S. Physical Therapy
or view top insider-selling stocks.

Which major investors are buying U.S. Physical Therapy stock?

USPH stock was acquired by a variety of institutional investors in the last quarter, including Scout Investments Inc., Fenimore Asset Management Inc., and Everence Capital Management Inc.. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, and Regg E Swanson.
View insider buying and selling activity for U.S. Physical Therapy
or or view top insider-buying stocks.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $109.94.

How much money does U.S. Physical Therapy make?

U.S. Physical Therapy has a market capitalization of $1.42 billion and generates $481.97 million in revenue each year. The company earns $40.04 million in net income (profit) each year or $2.82 on an earnings per share basis.

How many employees does U.S. Physical Therapy have?

U.S. Physical Therapy employs 2,550 workers across the globe.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is www.usph.com.

Where are U.S. Physical Therapy's headquarters?

U.S. Physical Therapy is headquartered at 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]

This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.